Business Context and Reporting Period
Company: Reinsurance Group of America, Incorporated (RGA)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: RGA is a leading global provider of life reinsurance and financial solutions, including traditional reinsurance (life, health, disability) and financial solutions (longevity, asset-intensive products, pension risk transfer). As of September 30, 2025, the company held $4.3 trillion of life reinsurance in force and total assets of $152.0 billion.
Key Financial Metrics
| Metric (in millions) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Premiums | $4,280 | $4,391 | $12,450 | $13,687 |
| Net Investment Income | $1,475 | $1,188 | $4,115 | $3,231 |
| Total Revenues | $6,204 | $5,651 | $17,063 | $16,866 |
| Net Income (GAAP) | $255 | $158 | $724 | $574 |
| Net Income to Shareholders | $253 | $156 | $719 | $569 |
| Diluted EPS | $3.81 | $2.33 | $10.78 | $8.53 |
| Adjusted Operating Income (Pre-tax) | $385 | $314 | $1,291 | $1,321 |
| Total Assets | $152,003 | $118,675 | $152,003 | $118,675 |
| Shareholders' Equity | $12,978 | $10,816 | $12,978 | $10,816 |
| Long-term Debt | $5,734 | $5,042 | $5,734 | $5,042 |
| Cash & Cash Equivalents | $4,625 | $3,326 | $4,625 | $3,326 |
Material Changes vs. Prior Period
- Profitability Surge: Net income available to shareholders increased 62% in Q3 2025 ($253M) compared to Q3 2024 ($156M), driven by a major reinsurance transaction with Equitable Holdings, Inc., favorable investment income, and reduced investment-related losses.
- Equitable Transaction Impact: On July 31, 2025, RGA assumed a 75% quota share of Equitable's in-force individual life insurance liabilities (approx. $12 billion). This transaction contributed $37 million to U.S. Financial Solutions adjusted operating income in Q3 and generated a $21 million gain from the recapture of previously assumed risks in the U.S. Traditional segment.
- Investment Performance: Net investment income rose 24% in Q3 2025 due to a larger invested asset base and higher new money rates. Investment-related losses improved significantly, turning into a net gain of $13M in Q3 2025 from a loss of $78M in Q3 2024.
- Assumption Updates: The annual assumption review in Q3 2025 resulted in a $149 million loss, primarily due to updated mortality assumptions in the U.K. (EMEA Traditional segment). This contrasts with a $58 million loss in the same period in 2024.
- Premiums: Net premiums decreased 3% in Q3 2025 and 9% in the nine-month period compared to 2024, primarily due to the timing of single-premium pension risk transfer (PRT) transactions executed in the prior year.
Guidance, Outlook, and Risks
- Capital Deployment: The company continues to return capital to shareholders. In Q3 2025, it declared a quarterly dividend of $0.93 per share. As of September 30, 2025, $425 million remained under its $500 million share repurchase authorization.
- Liquidity: Management believes liquidity sources are sufficient to cover claims and obligations for the next 12 months. The company maintains $850 million in available revolving credit and $508 million in FHLB borrowing capacity.
- Key Risks:
- Integration Risk: Risks associated with integrating the Equitable reinsurance transaction, including potential undiscovered liabilities and reliance on Equitable for data and administration.
- Mortality and Morbidity: Remains the most significant risk, particularly highlighted by the unfavorable mortality assumption updates in the U.K.
- Interest Rate Sensitivity: While the company manages duration risk, sustained changes in interest rates could impact investment yields and liability valuations.
- Counterparty Risk: Exposure to the financial stability of ceding companies and retrocessionaires, though the company notes no material defaults historically.
Investor Verification Checklist
- Equitable Transaction Details: Verify the specific terms, risk transfer mechanisms, and integration progress of the $12 billion Equitable reinsurance deal.
- U.K. Mortality Assumptions: Review the specific actuarial changes driving the $149 million assumption update loss in the EMEA Traditional segment.
- Investment Portfolio Quality: Assess the $6.5 billion in gross unrealized losses on fixed maturity securities and the adequacy of the $161 million allowance for credit losses.
- Debt Covenants: Confirm continued compliance with debt covenants, specifically the minimum consolidated net worth of $5.8 billion and the 35% debt-to-capitalization ratio.
- Share Repurchase Activity: Monitor the pace of the remaining $425 million share repurchase authorization and its impact on earnings per share.